SV

Sunita Vipin Khanduri

Active Director Director DIN 10061298
DIN 10061298 First appointment Mar 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2023
Shareholding value •••• Premium profile

About Sunita Vipin Khanduri

Data last updated:

Sunita Vipin Khanduri is a Director at Amro Biotech Private Limited (since 2023). The company operates in Pharma. Amro Biotech Private Limited reported revenue of ₹29.3 Lakh (FY 2025).

DIN 10061298
Primary Designation Director
Industry Pharma
First Appointment 03 Mar 2023
Oldest Company Age 3 yrs
Largest company Amro Biotech Private Limited · ₹29.3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Amro Biotech Private Limited U47721MH2023PTC398476
Director03 Mar 20232023₹29.3 Lakh (FY 2025)Active

Board colleagues of Sunita Vipin Khanduri

Directorship timeline

Open interactive timeline →
Amro Biotech Private Limited
Premium access

Shareholding and investment profile for Sunita Vipin Khanduri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sunita Vipin Khanduri

Sunita Vipin Khanduri currently holds 1 directorship: Amro Biotech Private Limited (Director, since 03 Mar 2023, revenue ₹29.3 Lakh (FY 2025)).

Sunita Vipin Khanduri was first appointed on 03 Mar 2023 as Director at Amro Biotech Private Limited.

The current boards of Sunita Vipin Khanduri's companies include Seema Subhash Pant (Amro Biotech Private Limited), Vipin Dayanand Khanduri (Amro Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available